Here below are the publications (2) participated by Chiara Tarantelli along with Lorenzo Scalise (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).
Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma
eJHaem, 27 luglio 2022

2) Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models.
American Society of Hematology, https://ashpublications.org/bloodadvances/article/4/5/819/452604/Copanlisib-synergizes-with-conventional-and